Biodexa Pharmaceuticals Financial Overview
Biodexa Pharmaceuticals's market cap is currently $3.12M. The company's EPS TTM is $0; its P/E ratio is -0.08; Biodexa Pharmaceuticals is scheduled to report earnings on September 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
